|
TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation.
Circulation. 2003 Feb; 107(4):559-64.
Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ, Staberock M, de Feyter P, Muller R, Regar E, Degertekin M, Ligthart JM, Disco C, Backx B, Russell ME. |
|
Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial.
Am Heart J. 2003 Feb; 145(2):239-47.
Gurbel PA, Cummings CC, Bell CR, Alford AB, Meister AF, Serebruany VL; Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial. |
|
Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study.
Stroke. 2003 Ene; 34(12):e227-8. Epub 2003 Nov 20
Yamazaki M, Uchiyama S. |
|
Anticoagulants versus antiplatelet agents for acute ischemic stroke.
Stroke.. 2003 Ene; 34(6):1571-5. Epub 2003 May 22
Hankey GJ, Berge E, Sandercock P. |
|
Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: the Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy.
Am Heart J. 2003 Ene; 145(4):636-42.
Serebruany VL, Malinin AI, Callahan KP, Binbrek A, Van De Werf F, Alexander JH, Granger CB, Gurbel PA; Assessment of the Safety and Efficacy of a New Thrombolytic Agent platelet substudy |
|
Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial.
Stroke. 2003 Ene; 34(4):840-8.
Matias-Guiu J, Ferro JM, Alvarez-Sabin J, Torres F, Jimenez MD, Lago A, Melo T; TACIP Investigators. |
|
Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease.
Eur Heart J.. 2003 Ene; 24(1):86-93.
Oldgren J, Wallentin L, Grip L, Linder R, Norgaard BL, Siegbahn A |
|
Reduced thrombus cohesion in an ex vivo human model of arterial thrombosis induced by clopidogrel treatment: kinetics of the effect and influence of single and double loading-dose regimens.
Thromb Res. 2003 Ene; 111(1-2):19-27.
Bal dit Sollier C, Mahe I, Berge N, Simoneau G, Bergmann JF, Drouet L. |
|
Diabetes and Progression of Carotid Atherosclerosis: The Insulin Resistance Atherosclerosis Study.
Arterioscler Thromb Vasc Biol. 2003 Ene; 23:1035-1041.
Lynne E. Wagenknecht, Daniel Zaccaro, Mark A. Espeland, Andrew J. Karter, Daniel H. OLeary, and Steven M. Haffner |
|
C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease The PRIME Study
Arterioscler Thromb Vasc Biol . 2003 Ene; 23:1255-1261. published online before print 2004 May 29
Gérald Luc; Jean-Marie Bard; Irène Juhan-Vague; Jean Ferrieres; Alun Evans; Philippe Amouyel; Dominique Arveiler; Jean-Charles Fruchart; Pierre Ducimetiere on behalf of the PRIME Study Group |
|
Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting.
Thromb Res. 2003 Ene; 111(3):171-7.
Fernandes LS, Conde ID, Wayne Smith C, Kansas GS, Snapp KR, Bennet N, Ballantyne C, McIntire LV, O´Brian Smith E, Klem JA, Mathew S, Frangogiannis N, Turner NA, Maresh KJ, Kleiman NS. |
